These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11017933)

  • 1. Enzymatic mutation detection in the P53 gene.
    Inganäs M; Byding S; Eckersten A; Eriksson S; Hultman T; Jorsback A; Löfman E; Sabounchi F; Kressner U; Lindmark G; Tooke N
    Clin Chem; 2000 Oct; 46(10):1562-73. PubMed ID: 11017933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic mutation detection method evaluated for detection of p53 mutations in cDNA from breast cancers.
    Norberg T; Klaar S; Lindqvist L; Lindahl T; Ahlgren J; Bergh J
    Clin Chem; 2001 May; 47(5):821-8. PubMed ID: 11325884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated fluorescent analysis procedure for enzymatic mutation detection.
    Del Tito BJ; Poff HE; Novotny MA; Cartledge DM; Walker RI; Earl CD; Bailey AL
    Clin Chem; 1998 Apr; 44(4):731-9. PubMed ID: 9554483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An endonuclease/ligase based mutation scanning method especially suited for analysis of neoplastic tissue.
    Huang J; Kirk B; Favis R; Soussi T; Paty P; Cao W; Barany F
    Oncogene; 2002 Mar; 21(12):1909-21. PubMed ID: 11896624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of resolvases T4 endonuclease VII and T7 endonuclease I in mutation detection.
    Babon JJ; McKenzie M; Cotton RG
    Mol Biotechnol; 2003 Jan; 23(1):73-81. PubMed ID: 12611271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of enzymatic mutation detectiontrade mark in hereditary nonpolyposis colorectal cancer.
    Otway R; Tetlow N; Hornby J; Kohonen-Corish M
    Hum Mutat; 2000; 16(1):61-7. PubMed ID: 10874307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic mutation detection (EMD) of novel mutations (R565X and R1523X) in the FBN1 gene of patients with Marfan syndrome using T4 endonuclease VII.
    Youil R; Toner TJ; Bull E; Bailey AL; Earl CD; Dietz HC; Montgomery RA
    Hum Mutat; 2000 Jul; 16(1):92-3. PubMed ID: 10874320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of mutations by cleavage of DNA heteroduplexes with bacteriophage resolvases.
    Mashal RD; Koontz J; Sklar J
    Nat Genet; 1995 Feb; 9(2):177-83. PubMed ID: 7719346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mutation analysis of p53 and ST7 tumor suppressor genes in gastric carcinoma by DHPLC.
    Lu C; Xu HM; Ren Q; Ao Y; Wang ZN; Ao X; Jiang L; Luo Y; Zhang X
    World J Gastroenterol; 2003 Dec; 9(12):2662-5. PubMed ID: 14669308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different mutation profiles associated to P53 accumulation in colorectal cancer.
    López I; P Oliveira L; Tucci P; Alvarez-Valín F; A Coudry R; Marín M
    Gene; 2012 May; 499(1):81-7. PubMed ID: 22373952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.
    Gumerlock PH; Chi SG; Shi XB; Voeller HJ; Jacobson JW; Gelmann EP; deVere White RW
    J Natl Cancer Inst; 1997 Jan; 89(1):66-71. PubMed ID: 8978408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation detection using fluorescent enzyme mismatch cleavage with T4 endonuclease VII.
    Babon JJ; McKenzie M; Cotton RG
    Electrophoresis; 1999 Jun; 20(6):1162-70. PubMed ID: 10380755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic mutation detection. Phosphate ions increase incision efficiency of endonuclease VII at a variety of damage sites in DNA.
    Golz S; Greger B; Kemper B
    Mutat Res; 1998 May; 382(3-4):85-92. PubMed ID: 9691988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical cleavage of mismatch (CCM) to locate base mismatches in heteroduplex DNA.
    Tabone T; Sallmann G; Chiotis M; Law M; Cotton R
    Nat Protoc; 2006; 1(5):2297-304. PubMed ID: 17406471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for mutations by enzyme mismatch cleavage with T4 endonuclease VII.
    Youil R; Kemper BW; Cotton RG
    Proc Natl Acad Sci U S A; 1995 Jan; 92(1):87-91. PubMed ID: 7816853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low density DNA microarray for detection of most frequent TP53 missense point mutations.
    Rangel-López A; Maldonado-Rodríguez R; Salcedo-Vargas M; Espinosa-Lara JM; Méndez-Tenorio A; Beattie KL
    BMC Biotechnol; 2005 Feb; 5():8. PubMed ID: 15713227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sensitive method for detection of mutations--a PCR-based RNase protection assay.
    Murthy KK; Shen SH; Banville D
    DNA Cell Biol; 1995 Jan; 14(1):87-94. PubMed ID: 7832996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-step DGGE-based mutation scanning of the p53 gene: application to genetic diagnosis of colorectal cancer.
    Guldberg P; Nedergaard T; Nielsen HJ; Olsen AC; Ahrenkiel V; Zeuthen J
    Hum Mutat; 1997; 9(4):348-55. PubMed ID: 9101296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient screening of p53 mutations by denaturing gradient gel electrophoresis in colorectal tumors.
    Hamelin R; Jego N; Laurent-Puig P; Vidaud M; Thomas G
    Oncogene; 1993 Aug; 8(8):2213-20. PubMed ID: 8336944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay.
    Kashiwazaki H; Tonoki H; Tada M; Chiba I; Shindoh M; Totsuka Y; Iggo R; Moriuchi T
    Oncogene; 1997 Nov; 15(22):2667-74. PubMed ID: 9400993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.